Steven Caras, MD, PhD

A randomized, placebo-controlled trial to evaluate the efficacy and safety of AR19 (amphetamine sulfate) in adults with attention-deficit/hyperactivity disorder

Background: AR19 is a pellets-in-capsule, immediate-release amphetamine sulfate investigational formulation with physical and chemical barriers designed to resist manipulation to deter sn...

Steven Caras , MD, PhD;

Anthony Rostain , MD;

Stephen V. Faraone , PhD;

10/08/2020

Bioequivalence of a Manipulation-Resistant Formulation Immediate-Release Amphetamine Sulfate to Reference Immediate-Release Amphetamine Sulfate in Healthy Volunteers

Introduction: We compared the bioavailability of racemic amphetamine (d-amphetamine and l-amphetamine) from a manipulation-resistant immediate-release (IR) amphetamine sulfate capsule (AR...

Steven Caras , MD, PhD;

Terrilyn Sharpe , MSHS;

03/01/2019